Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Curr Opin Ophthalmol ; 31(5): 403-415, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-692439

ABSTRACT

PURPOSE OF REVIEW: To compile and report the ocular manifestations of coronavirus disease 2019 (COVID-19) infection and summarize the ocular side effects of investigational treatments of this disease. RECENT FINDINGS: Conjunctivitis is by far the most common ocular manifestation of COVID-19 with viral particles being isolated from tears/secretions of infected individuals. Multiple therapeutic options are being explored across a variety of medication classes with diverse ocular side effects. SUMMARY: Eye care professionals must exercise caution, as conjunctivitis may be the presenting or sole finding of an active COVID-19 infection. While no currently studied therapeutic agents have been found to reliably treat COVID-19, early vaccination trials are progressing and show promise. A video abstract is available for a more detailed summary. VIDEO ABSTRACT: http://links.lww.com/COOP/A36.


Subject(s)
Betacoronavirus/isolation & purification , Conjunctivitis, Viral/diagnosis , Coronavirus Infections/diagnosis , Drug-Related Side Effects and Adverse Reactions/etiology , Drugs, Investigational/adverse effects , Eye Diseases/chemically induced , Pneumonia, Viral/diagnosis , Tears/virology , COVID-19 , Conjunctivitis, Viral/drug therapy , Conjunctivitis, Viral/virology , Drug-Related Side Effects and Adverse Reactions/prevention & control , Eye Diseases/prevention & control , Humans , Pandemics , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL